Dual Agonists Under Investigation Tirzepatide (Mounjaro) was approved by the FDA on May 13, 2022 for the treatment of type 2 diabetes in adults, making it the first and only GIP/GLP-1 receptor agonist
After the first four weeks at 2 mg, most protocols move to 4 mg for another four weeks, then 8 mg, and finally 12 mg
Whats the difference between compounded semaglutide and brand-name Ozempic or Wegovy
Gut balance, muscle retention, and nutritional sufficiency are all target areas, with ingredients like protein, prebiotic fibre, calcium, and collagen highlighted.Another expanding category of products is supplements which naturally mimic the effects of semaglutide
Melynda Fenn, FNP-C, reviews all of this with you at your consultation, after labs
So far, that form factor has proven to be a hit with consumers and investors alike